The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil
- 1 December 1989
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 46 (6) , 674-685
- https://doi.org/10.1038/clpt.1989.204
Abstract
The effects of alteration of gastric pH and food on the pharmacokinetics of 200 mg doses of cefpodoxime proxetil tablets were studied in two separate randomized, open label, crossover studies in healthy subjects. In the pH study (n = 17 subjects), there was a lead-in period done under fasting conditions, followed by randomization to a four-way crossover of pentagastrin (6 .mu.g/kg, subcutaneously), ranitidine (150 mg orally, 10 and 2 hours before dosing with the antibiotic), sodium bicarbonate (12.6 gm), or aluminum hydroxide (120 cc). Gastric pH was determined by nasogastric aspirates before and 10 minutes after the intervention, just before the antibiotic was given. Peak plasma concentrations (Cmax) and area under plasma concentration-time curve (AUC) were highest in fasting and pentagastrin periods and were 35% to 50% lower for all of the other periods (p < 0.0001). Gastric pH and Cmax and AUC were inversely related (r = 0.66 and r = 0.62; p < 0.0001 for both). In the food study (n = 16 subjects), there were two lead in periods, one done while subjects were fasting and one while they were normal diet, followed by randomization to a four-way crossover of either high or low protein diets, or high or low fat diets. There were six meals in each diet. Dosing with the antibiotic was done at the midpoint of the fourth meal. Cmax and AUC were 22% to 34% higher for all diets than for the fasting period (p < 0.0001), whereas the time to Cmax was unchanged. These studies demonstrated that absorption of cefpodoxime proxetil is best at low gastric pH or in the presence of food, which suggests that the role of gastrointestinal function on the pharmacokinetic profile is complex.This publication has 9 references indexed in Scilit:
- Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteersAntimicrobial Agents and Chemotherapy, 1989
- Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjectsAntimicrobial Agents and Chemotherapy, 1989
- Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)Antimicrobial Agents and Chemotherapy, 1988
- Effect of food on nifedipine pharmacokineticsClinical Pharmacology & Therapeutics, 1987
- In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1987
- Pharmacokinetics and bactericidal activity of cefuroxime axetilAntimicrobial Agents and Chemotherapy, 1985
- The Effect of Dietary Protein on the Clearance of Allopurinol and OxypurinolNew England Journal of Medicine, 1985
- Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.British Journal of Clinical Pharmacology, 1984
- Healing of Duodenal Ulcer with an Antacid RegimenNew England Journal of Medicine, 1977